Sep 17, 2009 - OSI Pharmaceuticals, Inc. announced today that the U.S. Patent & Trademark Office has issued a “Notice of Allowance” in OSI's reissue application for U.S. Patent No.5,747,498 (the ˜498) composition of matter patent for Tarceva® (erlotinib).
The details can be read here.
No comments:
Post a Comment